2024/10/18 19:32:29 | |
---|---|
Price | |
39.105 EUR | |
Difference | -0.48% (-0.19) |
ISIN | NL0015001WM6 |
Symbol | QGEN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,809 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 39.25 EUR |
High | 39.52 EUR |
Low | 39.105 EUR |
Close (prev. day) | 39.295 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
Related Futures | 35 |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 19:32:29 | |
---|---|
Price | |
39.105 EUR | |
Difference | -0.48% (-0.19) |
ISIN | NL0015001WM6 |
Symbol | QGEN |
Exchange | Duesseldorf |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 8,809 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 39.25 EUR |
High | 39.52 EUR |
Low | 39.105 EUR |
Close (prev. day) | 39.295 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +6.57% | +5.19% | -15.16% |
Perf (abs.) | +2.41 | +1.93 | -6.99 |
Beta | 0.50 | 0.41 | 0.51 |
Volatility | 20.89 | 21.16 | 22.12 |
Ø price 5 days | Ø volume 5 days (pcs.) | 39.740 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 40.222 EUR (45) |
Ø price 100 days | Ø volume 100 days (pcs.) | 39.978 EUR (25) |
Ø price 250 days | Ø volume 250 days (pcs.) | 39.715 EUR (22) |
YTD High | date | 43.144 EUR (2024/01/09) |
YTD Low | date | 36.355 EUR (2024/04/19) |
52 Weeks High | date | 43.144 EUR (2024/01/09) |
52 Weeks Low | date | 34.052 EUR (2023/10/30) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/10/18 | 17:39 | 39.38 EUR | 28.90 | 4,117 |
Vienna Stock Exchange | 2024/10/18 | 17:32 | 39.32 EUR | 0.00 | 4 |
Tradegate | 2024/10/18 | 22:26 | 39.62 EUR | 0.77 | 75 |
Stuttgart | 2024/10/18 | 21:59 | 39.41 EUR | 0.04 | 159 |
NYSE | 2024/10/18 | 22:00 | 43.00 USD | 43.80 | 13,213 |
Munich | 2024/10/18 | 08:04 | 39.60 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/10/18 | 17:30 | 43.54 EUR | 0.00 | 1 |
Hanover | 2024/10/18 | 08:16 | 39.25 EUR | 0.00 | 1 |
Hamburg | 2024/10/18 | 08:16 | 39.25 EUR | 0.00 | 3 |
Frankfurt | 2024/10/18 | 17:44 | 39.55 EUR | 0.09 | 7 |
Euronext Milan MTF Trading After Hours | 2024/04/08 | 18:55 | 39.18 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/10/18 | 17:44 | 39.375 EUR | 0.00 | 1 |
Duesseldorf | 2024/10/18 | 19:32 | 39.105 EUR | 0.00 | 7 |
Berlin | 2024/10/18 | 08:04 | 39.37 EUR | 0.00 | 1 |
QIAGEN NV |
- - |
Hulsterweg 82 - 5912 PL Venlo |
Telefon: +31-77-355-66-00 |
Fax: + |
E-mail: qiagen@qiagen.com |
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands. |
Thierry Bernard | Chairman of Managing Board |
Jonathan Sheldon | Member of Executive Committee |
Antonio Santos | Member of Executive Committee |
Fernando Beils | Member of Executive Committee |
Jean-Pascal Viola | Member of Executive Committee |
Nitin Sood | Member of Executive Committee |
Roland Sackers | Member of Executive Committee |
Stephany Foster | Member of Executive Committee |
Lawrence Rosen | Chairman of Supervisory Board |
Elaine Mardis | Member of Supervisory Board |
Eva Pisa | Member of Supervisory Board |
Metin Colpan | Member of Supervisory Board |
Ross Levine | Member of Supervisory Board |
Toralf Haag | Member of Supervisory Board |
Bert van Meurs | Member of Supervisory Board |
Elizabeth Tallett | Member of Supervisory Board |
Eva van Pelt | Member of Supervisory Board |
Stephen Rusckowski | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer